Lv1
88 积分 2026-01-10 加入
Comparison of tegoprazan-based dual therapy and bismuth-containing quadruple therapy for Helicobacter pylori eradication
5个月前
已关闭
Comparison of tegoprazan-based dual therapy and bismuth-containing quadruple therapy for Helicobacter pylori eradication
5个月前
已完结
Beneficial effects of a compound probiotic in Helicobacter pylori-infected patients aged over 40 years: An open-label randomised clinical trial
7个月前
已关闭
Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial
7个月前
已关闭
Cost-effectiveness of first-line regimens for Helicobacter pylori infection in the United States
7个月前
已完结
An Open‐Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7‐Day Triple Therapy With Bismuth Versus 14‐Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents
8个月前
已完结
皖公网安备34019202002308
